Overview

Comparison of Treatment Modalities in Poor Responders Undergoing IVF

Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
The accurate identification and efficient management of poor responders remains one of the most enigmatic challenges in assisted reproductive technology (ART). The investigators study will compare the letrozole/antagonist protocol to the hMG/antagonist protocol in women who poor responders.
Phase:
N/A
Details
Lead Sponsor:
Ercan Bastu
Treatments:
Letrozole
Menotropins